Silencing AFAP1‐AS1 can inhibit the proliferation, migration, and invasion of tongue squamous cell carcinoma both in vivo and in vitro, and may become a potential diagnostic and prognostic biomarker and therapeutic target for tongue squamous cell carcinoma.34 This evidence concerns the gene AFAP1 and tongue squamous cell carcinoma.